Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate cancer.
about
Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells.Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
P2860
Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@en
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@nl
type
label
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@en
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@nl
prefLabel
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@en
Novel therapeutic strategies f ...... ion-resistant prostate cancer.
@nl
P2860
P356
P1476
Novel therapeutic strategies f ...... tion-resistant prostate cancer
@en
P2093
Naohiro Fujimoto
Tetsuro Matsumoto
P2860
P304
P356
10.1586/ECP.10.119
P407
P577
2010-11-01T00:00:00Z